HartmutKoeppenMD

Pathology • South San Francisco, CA

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Koeppen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Koeppen's full profile

Already have an account?

Office
1 DNA Way
South San Francisco, CA 94080

Education & Training

University of ChicagoFellowship, Hematopathology, 1994 - 1997
University of ChicagoResidency, Pathology-Anatomic and Clinical, 1990 - 1994
Albert Ludwigs University Faculty of MedicineClass of 1984

Certifications & Licensure

IL State Medical License 1993 - 2017
TX State Medical License 2008 - 2015
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Hematology

Publications & Presentations

PubMed

Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade.
Habib Hamidi, Yasin Senbabaoglu, Niha Beig, Juliette Roels, Cyrus Manuel
Cancer Cell. 2024-12-09
3 citations
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy.
Xiao Li, Jeffrey Eastham, Jennifer M Giltnane, Wei Zou, Andries Zijlstra
The Journal of Pathology. 2024-06-01
4 citations
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials.
Neil H Segal, Ignacio Melero, Victor Moreno, Neeltje Steeghs, Aurelien Marabelle
Nature Communications. 2024-05-15

Journal Articles

Differential Regulation of PD-L1 Expression by Immune and Tumor Cells in NSCLC and the Response to Treatment with Atezolizumab (Anti–PD-L1)
Alan Sandler, David S Shames, Hartmut Koeppen, Jamie Chaft, Scott N Gettinger, Alexander Spira, Daniel S Chen, Naiyer A Rizvi, David R Spigel, Proceedings of the National Academy of Sciences

Abstracts/Posters

Pharmacodynamic Effects and Immune Correlates of Response to the CD20/CD3 Bispecific Antibody Mosunetuzumab in Relapsed or Refractory Non-Hodgkin Lymphoma
Hartmut Koeppen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019